Thyroid cancer is a frequently encountered endocrine malignancy. Despite the favorable
prognosis of this disease, 15–20% of differentiated thyroid cancer (DTC) cases and most …

Thyroid cancer comprises different clinical and histological entities. Whereas differentiated
(DTCs) malignancies are sensitive to radioiodine therapy, anaplastic (ATCs) and medullary …

Context: Five to 10% of patients with differentiated thyroid cancers (DTC) develop invasive
and/or distant metastatic disease that is marginally improved with standard therapies …

Background Papillary thyroid cancer has been associated with chronic inflammation. A
systematic understanding of immune cell infiltration in PTC is essential for subsequent …

Immune cells play critical roles in tumor prevention as well as initiation and progression.
However, immune-resistant cancer cells can evade the immune system and proceed to form …

Hepatocellular carcinoma (HCC) is a common malignant tumour, especially in Asia. Its
prognosis is poor, and there are limited methods for predicting patient survival. This study …

Purpose: To evaluate MHC class I expression on papillary thyroid cancer (PTC) and analyze
changes in MHC expression and associated immune activation with current and …

Hashimoto's thyroiditis (HT) is the most common autoimmune disease in humans frequently
leading to hypothyroidism. HT is characterized by a cellular immune response with …

In the past decade, the field of cancer immunotherapy has been revolutionized by immune
checkpoint blockade (ICB) technologies. Success across a broad spectrum of cancers has …

Recent success in immunomodulating strategies in lung cancer and melanoma has
prompted much enthusiasm in their potential to treat other advanced solid malignancies …